A case report revealing acute onset psychosis and cognitive impairment as primary manifestation in relapsing-remitting multiple sclerosis by Nandy, Anirban et al.
 
  
 
Aalborg Universitet
A case report revealing acute onset psychosis and cognitive impairment as primary
manifestation in relapsing-remitting multiple sclerosis
Nandy, Anirban; Nielsen, Michael; Hilt, Claudia; Mogensen, Poul Henning; Yavarian, Yousef
Published in:
Clinical Case Reports
DOI (link to publication from Publisher):
10.1002/ccr3.2781
Creative Commons License
CC BY 4.0
Publication date:
2020
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Nandy, A., Nielsen, M., Hilt, C., Mogensen, P. H., & Yavarian, Y. (2020). A case report revealing acute onset
psychosis and cognitive impairment as primary manifestation in relapsing-remitting multiple sclerosis. Clinical
Case Reports, 8(5), 833-836. https://doi.org/10.1002/ccr3.2781
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Clin Case Rep. 2020;8:833–836.    | 833wileyonlinelibrary.com/journal/ccr3
1 |  INTRODUCTION
Multiple sclerosis (MS) is a demyelinating disorder of the 
central nervous system. Neuropsychiatric symptoms have 
previously been reported as a rare manifestation of MS,1 yet 
onset of MS with psychosis is rarely encountered especially 
with relapsing-remitting type of multiple sclerosis (RRMS). 
Untreated psychosis in patients with MS can adversely impact 
on MS medication, levels of disability, and quality of life.1 
A 23-year-old Caucasian male was admitted due to sudden 
onset of cognitive deficits, agitation, aggressive self-harming 
behavior, and neurological symptoms with paresis of the right 
upper extremity along with ataxic gait. His clinical, radiolog-
ical, and laboratorial examinations initially lead to the sus-
picion of ADEM, eventually diagnosed with RRMS. Acute 
onset of neuropsychotic symptoms with MRI brain verified 
fulminant contrast enhancing ovoid lesions, both nodular 
and ring-enhancing involving both cerebral hemispheres, re-
sponse to high dose of steroids and plasma exchange, with a 
relatively short interval between psychiatric and neurological 
signs indicate a high likelihood that acute psychosis in our 
patient could be a manifestation of underlying MS.
2 |  CASE REPORT
A 23-year-old previously healthy Caucasian male, university 
student with no previous psychiatric history, was hospital-
ized with a subacute onset, four-day anamnesis of confu-
sion, extreme restlessness, and diffuse cognitive deficits. 
Due to aggressive self-harming behavior, paranoia, suicidal 
thoughts, and motor restlessness, psychiatric consultation 
was requested for assistance. There was no history of drug 
or alcohol abuse, and no known family history of mood or 
psychotic disorder.
A general examination revealed no rashes and normal 
vital parameters. Physical examination showed decreased 
motor function of the right lower extremity along with ataxic 
gait without any signs of an underlying myopathy. He was 
awake but remained confused, agitated, restless, had agnosia, 
and was not able to recognize either his mother or girlfriend. 
During admission, the patient expressed unrealistic and ir-
relevant thoughts. Furthermore, increased latency to give 
his personal data such as birth-date was observed. He was 
aggressive with suicidal thoughts. These symptoms had dra-
matically worsened within 2 days prior to admission. There 
Received: 27 October 2019 | Revised: 2 February 2020 | Accepted: 4 February 2020
DOI: 10.1002/ccr3.2781  
C A S E  R E P O R T
A case report revealing acute onset psychosis and cognitive 
impairment as primary manifestation in relapsing-remitting 
multiple sclerosis
Anirban Nandy1  |   Michael Nielsen1 |   Claudia Hilt1 |   Poul Henning Mogensen1 |   
Yousef Yavarian2
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
1Department of Neurology, Aalborg 
University Hospital, Aalborg, Denmark
2Department of Radiology, Aalborg 
University Hospital, Aalborg, Denmark
Correspondence
Anirban Nandy, Department of 
Neurology, Aalborg University Hospital, 
Ladegaardsgade 5, 9000 Aalborg, Denmark.
Email: a.nandy@rn.dk
Abstract
Acute psychosis and cognitive impairment is a significant problem in RRMS. As it 
concerns in relatively young age group, our case report underscores the importance 
of early recognition which could impose diagnostic challenge in multiple sclerosis.
K E Y W O R D S
acute psychosis, atypical RRMS, cognitive impairment, early MS presentation
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were no associated seizures or headaches. He was afebrile 
(37.1°) with peripheral oxygen saturation 98%, blood pres-
sure (135/67 mmHg), respiratory rate (21 breaths/min), and 
heart rate (83 beats/min). The initial serum biochemistry 
showed results within normal parameters for hematology, 
electrolytes, infection parameters, and thyroid test (includ-
ing thyroid antibodies). Acute routine cerebrospinal fluid 
examination revealed 5 leukocytes (mononuclear), lactate 
1.6  mmol/L, mildly elevated protein 0.56  g/L and glucose 
3.6  mmol/L, normal IgG, and negative oligoclonal bands. 
Intrathecal Herpes simplex virus, Varicella zoster, and 
Borrelia PCRs were negative. Cytomegalovirus IgG was also 
negative.
CT-cerebrum showed multiple low-density lesions with-
out intracranial hemorrhages, ischemia or space-occupying 
lesions. MRI brain showed fulminant contrast enhancing 
ovoid lesions, both nodular and ring-enhancing involving 
both cerebral hemispheres involving callososeptal interface, 
also including left infratentorial involving pons and medulla 
oblongata raising suspicion of severe demyelination disor-
ders (eg, acute disseminated encephalomyelitis (ADEM) or 
MS), malignancy and neuroinfection (Figure 1). No medul-
lary lesions were found (Figure 3).
Further blood test revealed negative Quantiferon TB test, 
toxoplasma serology, HIV 1 + 2 and viral hepatitis screen-
ing. Control cerebrospinal fluid analysis 5  weeks after the 
initial presentation showed leukocytes 3 (mononuclear), 
lactate 1.7 mmol/L, protein 0.55 g/L, glucose 3.4 mmol/L, 
high IgG ratio, and positive oligoclonal bands. Serology for 
autoimmune synaptic encephalitis was negative. Analysis 
of cerebrospinal fluid for markers of cancer and computer 
tomography of thorax and abdomen did not shown signs of 
malignancy.
ECG showed sinus rhythm with frequency 80/min with-
out ST segment deviation. Transthoracic echocardiography 
showed physiological valve functions with ejection fraction 
over 60 mL.
Neuropsychological evaluation revealed mini-mental state 
examination (MMSE) 25, with decreased executive function, 
processing speed, and associations. In conclusion, cognitive 
reduction due to organic pathology.
Control MRI brain after 5  weeks from the first scan 
showed partial regression of the lesion load with significant 
reduction of contrast enhancement and DWI signals (Figure 
2). The patient treated with high-dose intravenous methyl-
prednisolone and 6 cycles of plasmapheresis between the two 
MRI brain scans. Follow-up of 6 weeks after symptom onset 
showed near normal cognitive and physical function. No sen-
sory or motor deficit was found on examination. The psychi-
atric symptoms had resolved completely. He reported slight 
concentration difficulties and tiredness. Immunomodulatory 
treatment with Cladribine had been initiated with further fol-
low-up at MS outpatient clinic.
3 |  DISCUSSION
Neuroadiologically and clinically ADEM seems less likely 
due to involvement of callososeptal interface and lack of 
previous infection or vaccination in anamnesis. Multifocal 
lymphoma and primary brain tumor were also less likely 
due to atypical localization, and because there was only 
one lesion with diffusion restriction, but all other lesions 
were with T2 shine through phenomenon (Figure 1A, B, and 
F). In addition, perfusion scan was performed, which did 
not show increased perfusion. Brain spectroscopy showed 
increased choline, but almost normal N- acetyl-aspartate 
(NAA), which points away from tumor and lymphomas 
(Figure 1E). Spectroscopic studies in MS typically show 
increased choline and normal NAA, which was the case 
with our patient.2,3 In literature, increased lipid and lactate 
has also been described,4 which we have not found in this 
patient, perhaps because it depends on which MS phase 
spectroscopy been executed. No medullary lesions were re-
vealed (Figure 3).
The collected information narrowed the list of differen-
tial diagnosis between demyelinating diseases. A control 
cerebrospinal fluid investigation after 5 weeks showed high 
IgG index and oligoclonal bands, suggesting the probable 
diagnosis of relapsing-remitting multiple sclerosis (RRMS). 
Control MRI scan showed clear regression of contrast en-
hancement on T1 + contrast and signal on DWI sequences 
(Figure 2A,B), but MS plaques were still high signaling on 
T2-weighted sequence (Figure 2C).
Psychosis in multiple sclerosis considered as a rare onset 
manifestation.1,5 Cognitive impairment is part of the clini-
cal spectrum of multiple sclerosis (MS). Depending on the 
disease phase and type, 40%-65% of MS patients develop 
various degrees of cognitive dysfunction. Prevalence rates of 
psychosis in MS are two three times higher than in the general 
population.5 Our patient was a young male who presented 
with acute psychotic symptoms with focal neurological defi-
cits. There was no previous history of any diseases. The MRI 
brain and spinal cord with contrast showed intense and ful-
minant attack of inflammation with nodular ring-enhancing 
lesions in both cerebral hemispheres without affecting the 
spinal cord, raised suspicion of ADEM, infection or demye-
linating disorder. Even though initial cerebrospinal fluid in-
vestigation was normal, a new cerebrospinal fluid study after 
5  weeks revealed positive oligoclonal bands and increased 
IgG index, ultimately diagnosing disseminated sclerosis of 
relapsing-remitting variant.
In the MAGNIMS study, 63 out of 191 patients with 
progressive MS were diagnosed with cognitive impairment 
(CI) (28.6%).6 In one study, cognitive impairment was di-
agnosed in 56.5% out of 23 PPMS patients.7 The larger 
Dutch study found that cognitive impairment was more se-
vere in PPMS and SPMS than in RRMS.8 The prevalence 
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of neuropsychiatric symptoms in MS can vary according 
to various series, and some authors report levels as high 
as 95%.6,7 Depressive symptoms are most frequent among 
these. Psychotic symptoms are rare as initial findings of MS.9 
The relationship between cognitive impairment and subcorti-
cal white matter pathology has been reported to be associate 
with significant periventricular lesion burdens, especially in 
the temporal region.10 This finding helps in understanding 
the biological basis for psychosis and brain areas involved 
in psychosis. Over the last decade, an increasing number of 
observations have provided evidence of a primary role of 
cortical pathology—that is, inflammatory focal lesions (cor-
tical lesions), atrophy and cortical thickness—in determining 
global and selective cognitive disability in MS.11,12
Our patient fulfills the criteria for MS since oligoclonal 
bands were present with positive MRI cerebrum findings. He 
was eventually started on prophylactic Cladribine therapy as 
a second-line treatment for MS.
Even though the patient continued to be mildly affected 
cognitively 4-5 weeks after the onset of symptoms, plasma-
pheresis along with atypical antipsychotic medications gave 
excellent result against his psychosis.
F I G U R E  1  Axial DWI (A) and 
corresponding ADC—map (B) show 
multiple MS plaques with peripheral high 
signal on DWI and T2 shine through on 
the ADC. On axial T2 flair (C) multiple 
high-signal intensity plaques are seen and 
on axial T1 + contrast (D) the vast majority 
of the plaques show ring enhancement. 
Spectroscopy (E) shows increased choline 
and almost normal NAA. Sagittal T2 (F) 
shows multiple MS plaques
F I G U R E  2  Control scanning axial 
T1 + control (a) and DWI (b) show the 
regression of contrast enhancement and 
high-signal intensity in general. Sagital T2 
(c) shows still multiple MS plaques
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4 |  CONCLUSION
In conclusion, acute onset psychosis and cognitive impairment 
is a significant problem in RRMS. Particularly in RRMS, the 
incidence of psychosis and CI is approximately 40%, involv-
ing complex attention, processing speed and memory and ex-
ecutive dysfunction, agitation, and self-harming behavior. As 
RRMS in relatively young age group, shown worsening of 
cognitive dysfunction with psychosis, our case report under-
scores the importance of early recognition of acute psychosis 
and cognitive impairment, which could impose a diagnostic 
challenge in multiple sclerosis.
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F I G U R E  3  During admission, 
contrast MRI of cervicothoracic STIR 
sequences did not show any medullary 
pathology
